Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Saved in:
Bibliographic Details
Title: Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Authors: Zheng SH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Zhou S; Department of Radiotherapy, The first affiliated hospital of Nanjing Medical University, Nanjing, China., Wang GN; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Head & Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China., Huang ZL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Liu SR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China., Chen C; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Tao YL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Chang H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Ding SR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Liao RN; Zhongshan Medical College, Sun Yat-sen University, Guangzhou, China., Chen C; Zhongshan Medical College, Sun Yat-sen University, Guangzhou, China., Xia YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Source: Translational cancer research [Transl Cancer Res] 2021 Nov; Vol. 10 (11), pp. 4624-4635.
Publication Type: Journal Article
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2219-6803
DOI:10.21037/tcr-21-1340